Healthcare Resource Utilization and Costs Among Commercially Insured Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States

Background: Endometrial cancer (EC) represents a substantial economic burden for patients in the United States. Patients with advanced or recurrent EC have a much poorer prognosis than patients with early-stage EC. Data on healthcare resource utilization (HCRU) and costs for patients with advanced o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Monica, Garside, Jamie, Nguyen, Joehl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637624/
https://www.ncbi.nlm.nih.gov/pubmed/37954059
http://dx.doi.org/10.36469/001c.88419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637624/
https://www.ncbi.nlm.nih.gov/pubmed/37954059
http://dx.doi.org/10.36469/001c.88419

Ejemplares similares